|
Drug Topics
Community
Pharmacists' Report
DrugTopics.com
November 1, 2011 |
REIMBURSEMENT
Officials with the NCPA and NACDS expressed their concerns to the CMS about Medicaid pharmacy reimbursement. » More
|
CONTINUING EDUCATION
In carrying out Risk Evaluation and Mitigation Strategies associated with long-acting opioids, the pharmacist plays a multidimensional role in this effort, which includes educating patients, prescribers, and the community at large, being vigilant to signs of overprescribing or abuse, and recognizing the biopsychosocial factors that put pain patients at risk for substance abuse. » Click here to login and take the exams.
|
ADVERTISEMENT
Resource Center: Oral Anticoagulation in Atrial Fibrillation
Atrial fibrillation afflicts more than 2.3 million persons in the United States and is expected to increase 2.5-fold by 2050. To find risk stratifying tools and articles on emerging oral anticoagulant therapies,
 click here. |
COMMUNITY PHARMACY
Independent pharmacies are outselling retail chain stores in 6 product categories, according to a new study from Hamacher Resource Group. » More |
DT BLOG
Pharmacists are legally required to counsel. But they are not compensated for their skill or time. Looking back over several decades of pharmacy practice and social change, an experienced pharmacist offers the obvious solution. » More |
Survey
a) Enhanced competition within the industry, resulting in even lower drug costs for PBM payer clients
b) Express Scripts' size advantage could reduce competition and increase long-term costs for payers
c) Increased pressures on retail pharmacies to compete in the market
d) Increased quality of PBM services across the industry as other PBMs strive to stay competitive
e) Minimal, if any
Respond here and see what your colleagues think too.
Want to see the results of our last survey about whether your pharmacy imposes a daily quota of filled prescriptions? Click here.
|
MEDICATION SAFETY
The use of antidepressants jumped 400% over a 10-year period, according to new data from the CDC. » More |
ASSOCIATION NEWS
Emphasizing pharmacists’ role in medication adherence and battling mandatory mail order plans are 2 of the top priorities for incoming NCPA President Lonny Wilson, DPh. » More |
|
Karl Rove and Robert Gibbs will be the keynote speakers at the 2012 Armada Specialty Pharmacy Summit to be held in Las Vegas, Nev., May 1 through 4. » More |
FDA ACTIONS
FDA has approved clobazam (Onfi, Lundbeck and Catalent Pharma Solutions) as adjunctive therapy for seizures associated with Lennox-Gastaut syndrome in patients aged 2 years and older. » More |
|
Confirm your
e-newsletter subscription click here.
To ensure future delivery of email newsletters from Drug Topics please take a moment to confirm your subscription by clicking here.
Thank you,
Drug Topics Staff |
Digital Edition |
|
|
|
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
|
